Anti-Aging Scientists Bet $1-Million on Who Will Die First

By MONEY MORNING STAFF REPORTS -

Two anti-aging scientists, both working on different longevity treatments, have made a shocking wager.

Doctor Dmitry Kaminskiy and Doctor Alex Zhavoronkov have made a bet that they'll live longer.

Whoever dies first, will leave $1 million to the other.

The only rule: They can't kill each other.

Dr. Zhavoronkoy is the CEO of the anti-aging drug company Insilico Medicine. He believes his company's therapies give him the advantage in the competition.

However, Kaminkiy is one year younger, which may prove to be a deciding factor. But it's not the only trick up his sleeve.

"Access to a few hundred million dollars, state of the art information systems and a venture fund investing in longevity companies also helps," says Kaminskiy.

No matter who wins, neither of them expect to claim the prize until well after their 100 birthday.

More: Can Humans Live Forever? Click here to see our exclusive presentation on the "Immorality Gene."

That's because there have recently been a series of medical breakthroughs that are redefining the very concept of aging.

Silicon Valley Venture Capitalist and biotech advisor, Michael Robinson says, "I expect it to be at least 100 years - probably longer - until we see a winner of this bet.

Companies aren't too eager to talk about this right now because it's so hard to believe, but the treatments in the development pipeline right now are literally undoing aging.

In the next decade it's possible that 100 will be looked at as the new 20."

Robinson credits this incredible longevity to two Nobel Prize winning discoveries.

In a recent presentation, he discussed the work being done at MIT, Harvard, Stanford, and top research facilities around the world.

"Aging happens on the cellular level. It's a fault in our chromosomes. We now have the ability to fix that fault," Robinson says. "We're using this in human cells and they're aging backwards by 25 years. It's incredible."

How long before these therapies leave the lab and becomes available to the general public?

Robinson says, "We're looking at a time line of about 24 months before the first one hits the market."

Click here to see his scientific demonstration of how this therapy works.